NHC on XASE, Health Care, National Healthcare Corp., job postings
Measures activity, not value. Not investment advice.
Shares fell 19% in a month after a 50% annual gain, while latest quarter revenue rose 6.6%.
GoodNet income rose 13% to $114.7M over the last 12 months
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
Industry
Services-skilled nursing care facilities (Health Care)
expected around 26 Feb 2027 (an estimate: a year ago it reported on 27 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $408.0M, net income $13.6M.
31 Dec 2021RevenueNet incomeNet losstallest bar $408.0M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$408.0M
$13.6M
30 Jun 2026
$408.0M
$40.3M
31 Mar 2026
$381.8M
$35.9M
31 Dec 2025
$386.5M
$24.8M
30 Sep 2025
$382.7M
$39.2M
30 Jun 2025
$374.9M
$23.7M
31 Mar 2025
$373.7M
$32.2M
31 Dec 2024
$369.4M
$6.1M
30 Sep 2024
$340.2M
$42.8M
30 Jun 2024
$300.7M
$26.8M
31 Mar 2024
$297.2M
$26.2M
31 Dec 2023
$300.9M
$28.4M
30 Sep 2023
$288.5M
$10.4M
30 Jun 2023
$282.6M
$16.3M
31 Mar 2023
$269.6M
$11.7M
31 Dec 2022
$264.6M
$6.4M
30 Sep 2022
$270.8M
-$2.4M
30 Jun 2022
$271.4M
$3.2M
31 Mar 2022
$279.0M
$15.3M
31 Dec 2021
$283.4M
$15.8M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$1.6B
$1.5B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+5.6%
+9.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$114.7M
$101.2M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$7.23
$6.47
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
63.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
9.8%
8.1%
-9.1%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
7.2%
6.7%
-7.6%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
10.5%
-44.4%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
$146.9M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$66.8M
$130.6M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$502.1M
$73.1M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$435.3M
-$57.5M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.45
0.06
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$71.81
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
26.1
24.7
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
1.9
3.2
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
2.2
3.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
2.7
2.2
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
1.3%
1.6%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+6.6%
$408.0M vs $382.7M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+23%
$12.5M vs $10.2M (quarter ended 30 Jun 2026)
Insider buy/sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$5.2M
bought $0, sold $5.2M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+12%
272 13F filers vs 242
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
67%
10.4M shares held by 13F filers (30 Sep 2026) of 15.7M outstanding (2 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
4.9%
770K shares sold short (30 Oct 2026) of 15.7M outstanding (2 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
4.5
770K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+1.9%
755K shares sold short in the report before, 770K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
64%
64% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 75%
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
26
26 articles in the last 7 days; its usual week has 4.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
5.8×
26 articles in the last 7 days; its usual week has 4.5.
Price $190.77 on 20 Nov 2026, +50% over 12 months (12-month range $127.36 to $247.94)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders sold a net $9.1M in the last 12 months (the 12 months before: -$8.0M).Revenue per quarter. Revenue $408.0M in the latest quarter, +6.6% on a year earlier.Capital spending per quarter. Capital spending $12.5M in the latest quarter, +23% on a year earlier.Institutional holders (13F filers). 272 13F filers reported holding it in the latest 13F quarter, +39% on a year earlier.Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $283.4M, +9.1% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $279.0M, +11% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $271.4M, +3.1% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $270.8M, -2.1% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $264.6M, -6.7% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $269.6M, -3.4% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $282.6M, +4.1% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $288.5M, +6.5% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $300.9M, +14% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $297.2M, +10% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $300.7M, +6.4% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $340.2M, +18% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $369.4M, +23% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $373.7M, +26% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $374.9M, +25% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $382.7M, +12% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $386.5M, +4.6% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $381.8M, +2.2% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $408.0M, +8.8% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $408.0M, +6.6% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $13.6M, +228% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $9.0M, +107% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $8.1M, -8.5% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $7.5M, -40% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $5.6M, -59% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $6.6M, -26% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $6.1M, -24% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $6.5M, -14% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $8.6M, +53% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $6.0M, -10% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $7.8M, +27% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $5.7M, -13% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $8.2M, -5.2% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $6.1M, +3.1% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $10.2M, +30% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $9.7M, +72% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $10.4M, +27% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $9.6M, +57% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $12.5M, +23% on a year earlier; public on 7 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 120; public on 14 Feb 2022
31 Mar 2022 report: 117; public on 16 May 2022
30 Jun 2022 report: 115; public on 15 Aug 2022
30 Sep 2022 report: 117; public on 14 Nov 2022
31 Dec 2022 report: 108; public on 14 Feb 2023
31 Mar 2023 report: 128; public on 15 May 2023
30 Jun 2023 report: 121; public on 14 Aug 2023
30 Sep 2023 report: 119; public on 14 Nov 2023
31 Dec 2023 report: 150; public on 14 Feb 2024
31 Mar 2024 report: 163; public on 15 May 2024
30 Jun 2024 report: 166; public on 14 Aug 2024
30 Sep 2024 report: 188; public on 14 Nov 2024
31 Dec 2024 report: 182; public on 14 Feb 2025
31 Mar 2025 report: 174; public on 15 May 2025
30 Jun 2025 report: 180; public on 14 Aug 2025
30 Sep 2025 report: 195; public on 14 Nov 2025
31 Dec 2025 report: 211; public on 17 Feb 2026
31 Mar 2026 report: 233; public on 15 May 2026
30 Jun 2026 report: 242; public on 14 Aug 2026
30 Sep 2026 report: 272; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $331K published
Month from 1 Dec 2021: $525K published
Month from 1 Jan 2022: $417K published
Month from 1 Feb 2022: $192K published
Month from 1 Apr 2022: $2.2M published
Month from 1 Jul 2022: $956K published
Month from 1 Aug 2022: $1.5M published
Month from 1 Oct 2022: $358K published
Month from 1 Jan 2023: $1.3M published
Month from 1 Feb 2023: $152K published
Month from 1 Apr 2023: $90K published
Month from 1 Jul 2023: $174K published
Month from 1 Oct 2023: $598K published
Month from 1 Dec 2023: $218K published
Month from 1 Apr 2024: $1.1M published
Month from 1 May 2024: $109K published
Month from 1 Jun 2024: $466K published
Month from 1 Jul 2024: $854K published
Month from 1 Oct 2024: $2.2M published
Month from 1 Jan 2025: $435K published
Month from 1 Apr 2025: $618K published
Month from 1 Jun 2025: -$369K published
Month from 1 Aug 2025: -$296K published
Month from 1 Sep 2025: $162K published
Month from 1 Oct 2025: $14K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 272 (30 Sep 2026), 1.5× its normal reading; higher than 100% of its own history.
Short interest spike: had 636K shares sold short in the 15 May 2026 report, 2.9× the same report last year Public on 28 May 2026.
In 12 months: 4 major agreements, 3 agreements ended, 1 director or officer change, 1 completed deal. Results releases and routine reports are left out.
Filed
What happened
Source
1 Jul 2026
Signed a major agreement; A major agreement ended; Completed an acquisition or asset saleSame filing: took on new debt
Reported lobbying spend: $10K in Q1 2018, $20K in Q4 2017. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
28 Feb 2018
Ended
The Ingram Group LLCfor National Healthcare Corporation
Issues related to Medicaid funding levels.Medicare/Medicaid
had 636K shares sold short in the 15 May 2026 report, 2.9× the same report last year.
Same report last year: 221K; its normal report is 309K.
See the evidence
This period
636K (the 15 May 2026 report)
Normal report (median of 24 earlier)
309K
Typical spread (median absolute deviation)
55K
How far from its usual level
+4.0
Same report last year
221K
History used
3,059 days
the 15 May 2026 report24 earlier reportsnormal: 309K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 690K shares sold short in the 30 Apr 2026 report, 2.7× the same report last year.
Same report last year: 260K; its normal report is 299K.
See the evidence
This period
690K (the 30 Apr 2026 report)
Normal report (median of 24 earlier)
299K
Typical spread (median absolute deviation)
44K
How far from its usual level
+6.0
Same report last year
260K
History used
3,044 days
the 30 Apr 2026 report24 earlier reportsnormal: 299K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 765K shares sold short in the 15 Apr 2026 report, 3.0× the same report last year.
Same report last year: 256K; its normal report is 292K.
See the evidence
This period
765K (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
292K
Typical spread (median absolute deviation)
38K
How far from its usual level
+8.4
Same report last year
256K
History used
3,029 days
the 15 Apr 2026 report24 earlier reportsnormal: 292K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 713K shares sold short in the 31 Mar 2026 report, 2.4× the same report last year.
Same report last year: 300K; its normal report is 292K.
See the evidence
This period
713K (the 31 Mar 2026 report)
Normal report (median of 24 earlier)
292K
Typical spread (median absolute deviation)
37K
How far from its usual level
+7.6
Same report last year
300K
History used
3,014 days
the 31 Mar 2026 report24 earlier reportsnormal: 292K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 581K shares sold short in the 13 Mar 2026 report, 1.8× the same report last year.
Same report last year: 320K; its normal report is 292K.
See the evidence
This period
581K (the 13 Mar 2026 report)
Normal report (median of 24 earlier)
292K
Typical spread (median absolute deviation)
36K
How far from its usual level
+5.4
Same report last year
320K
History used
2,996 days
the 13 Mar 2026 report24 earlier reportsnormal: 292K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 29 13F filers open a new position in the quarter ended 31 Mar 2024, 1.4× the same quarter last year.
Same quarter last year: 20; its normal quarter is 11.5.
See the evidence
This period
29 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
11.5
Typical spread (median absolute deviation)
3
How far from its usual level
+3.9
Same quarter last year
20
History used
3,835 days
the quarter ended 31 Mar 20248 earlier quartersnormal: 11.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
saw 32 13F filers open a new position in the quarter ended 31 Dec 2023, 2.9× the same quarter last year.
Same quarter last year: 11; its normal quarter is 10.5.
See the evidence
This period
32 (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
10.5
Typical spread (median absolute deviation)
1.5
How far from its usual level
+7.2
Same quarter last year
11
History used
3,744 days
the quarter ended 31 Dec 20238 earlier quartersnormal: 10.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 779K shares sold short in the 29 Dec 2023 report, 2.2× the same report last year.
Same report last year: 353K; its normal report is 364K.
See the evidence
This period
779K (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
364K
Typical spread (median absolute deviation)
53K
How far from its usual level
+5.3
Same report last year
353K
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 364K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 517K shares sold short in the 15 Mar 2023 report, 3.5× the same report last year.
Same report last year: 147K; its normal report is 205K.
See the evidence
This period
517K (the 15 Mar 2023 report)
Normal report (median of 24 earlier)
205K
Typical spread (median absolute deviation)
35K
How far from its usual level
+6.1
Same report last year
147K
History used
1,902 days
the 15 Mar 2023 report24 earlier reportsnormal: 205K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
spent $13.6M on capital projects in the quarter ended 31 Dec 2021, 3.3× the same quarter last year.
Same quarter last year: $4.2M; its normal quarter is $6.3M.
See the evidence
This period
$13.6M (the quarter ended 31 Dec 2021)
Normal quarter (median of 8 earlier)
$6.3M
Typical spread (median absolute deviation)
$1.5M
How far from its usual level
+3.3
Same quarter last year
$4.2M
History used
4,110 days
the quarter ended 31 Dec 20218 earlier quartersnormal: $6.3M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Showing the newest 40 of 57 entries; narrow the window or the kind of data to see older ones.
Not listed: 206 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001047335
Ticker
NHC
Domain
nhccare.com
Employer name
National Healthcare Corporation (1 unverified)
Fein
62-1294263 (1 unverified)
Hq location
TN|MURFREESBORO|37130 (1 unverified)
Lobbying client
national healthcare
Name
AdamsPlace, LLC, Buckley HealthCare Center, LLC, Caris HealthCare, L.P, City Center, L.P and 136 more